Replication of many human viruses is refractory to inhibition by endogenous cellular MicroRNAs

Journal of Virology

Volumn 88, Issue 14, 2014, Pages 8065-8076

  Bogerd, Hal P ^a   Skalsky, Rebecca L ^a,d   Kennedy, Edward M ^a   Furuse, Yuki ^a   Whisnant, Adam W ^a   Flores, Omar ^a   Schultz, Kimberly L W ^b   Putnam, Nicole ^b   Barrows, Nicholas J ^a   Sherry, Barbara ^c   Scholle, Frank ^c   Garcia Blanco, Mariano A ^a   Griffin, Diane E ^b   Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; MICRORNA; RNA; SMALL INTERFERING RNA; SMALL REGULATORY RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; GENE EXPRESSION; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS A; MEASLES VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EDITING; RNA SYNTHESIS; SEQUENCE ANALYSIS; SINDBIS VIRUS; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; YELLOW FEVER FLAVIVIRUS;

ANIMALS; CELL LINE; GENE SILENCING; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MICRORNAS; VIRUS REPLICATION; VIRUSES;

EID: 84904600856     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00985-14     Document Type: Article

References (83)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811. http://dx.doi.org/10.1038 /35888.
2. Hammond SM, Bernstein E, Beach D, Hannon GJ. 2000. An RNAdirected nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404:293-296. http://dx.doi.org/10.1038/35005107.
3. Elbashir SM, Lendeckel W, Tuschl T. 2001. RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev. 15:188-200. http://dx.doi.org/10.1101/gad.862301.
4. Cullen BR. 2004. Transcription and processing of human microRNA precursors. Mol. Cell 16:861-865. http://dx.doi.org/10.1016/j.molcel.2004.12.002.
5. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233. http://dx.doi.org/10.1016/j.cell.2009.01.002.
6. Doench JG, Petersen CP, Sharp PA. 2003. siRNAs can function as miRNAs. Genes Dev. 17:438-442. http://dx.doi.org/10.1101/gad.1064703.
7. Zeng Y, Yi R, Cullen BR. 2003. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl. Acad. Sci. U. S. A. 100:9779-9784. http://dx.doi.org/10.1073/pnas.1630797100.
8. Wilkins C, Dishongh R, Moore SC, Whitt MA, Chow M, Machaca K. 2005. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature 436:1044-1047. http://dx.doi.org/10.1038 /nature03957.
9. Schott DH, Cureton DK, Whelan SP, Hunter CP. 2005. An antiviral role for theRNAinterference machinery in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 102:18420-18424. http://dx.doi.org/10.1073/pnas.0507123102.
10. Lu R, Maduro M, Li F, Li HW, Broitman-Maduro G, Li WX, Ding SW. 2005. Animal virus replication and RNAi-mediated antiviral silencing in Caenorhabditis elegans. Nature 436:1040-1043. http://dx.doi.org/10.1038/nature03870.
11. Wang XH, Aliyari R, Li WX, Li HW, Kim K, Carthew R, Atkinson P, Ding SW. 2006. RNA interference directs innate immunity against viruses in adult Drosophila. Science 312:452-454. http://dx.doi.org/10.1126 /science.1125694.
12. Sabin LR, Zheng Q, Thekkat P, Yang J, Hannon GJ, Gregory BD, Tudor M, Cherry S. 2013. Dicer-2 processes diverse viral RNA species. PLoS One 8:e55458. http://dx.doi.org/10.1371/journal.pone.0055458.
13. Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, Lu R, Ansel KM, Heissmeyer V, Einav S, Jackson W, Doukas T, Paranjape S, Polacek C, dos Santos FB, Jalili R, Babrzadeh F, Gharizadeh B, Grimm D, Kay M, Koike S, Sarnow P, Ronaghi M, Ding SW, Harris E, Chow M, Diamond MS, Kirkegaard K, Glenn JS, Fire AZ. 2010. Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog. 6:e1000764. http://dx.doi.org/10.1371/journal.ppat.1000764.
14. Cullen BR, Cherry S, tenOever BR. 2013. Is RNA interference a physiologically relevant innate antiviral immune response in mammals? Cell Host Microbe 14:374-378. http://dx.doi.org/10.1016/j.chom.2013.09.011.
15. Ma E, MacRae IJ, Kirsch JF, Doudna JA. 2008. Autoinhibition of human dicer by its internal helicase domain. J. Mol. Biol. 380:237-243. http://dx.doi.org/10.1016/j.jmb.2008.05.005.
16. Flemr M, Malik R, Franke V, Nejepinska J, Sedlacek R, Vlahovicek K, Svoboda P. 2013. A retrotransposon-driven dicer isoform directs endogenous small interfering RNA production in mouse oocytes. Cell 155:807-816. http://dx.doi.org/10.1016/j.cell.2013.10.001.
17. Maillard PV, Ciaudo C, Marchais A, Li Y, Jay F, Ding SW, Voinnet O. 2013. Antiviral RNA interference in mammalian cells. Science 342:235-238. http://dx.doi.org/10.1126/science.1241930.
18. Li Y, Lu J, Han Y, Fan X, Ding SW. 2013. RNA interference functions as an antiviral immunity mechanism in mammals. Science 342:231-234. http://dx.doi.org/10.1126/science.1241911.
19. Neilson JR, Zheng GX, Burge CB, Sharp PA. 2007. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 21:578-589. http://dx.doi.org/10.1101/gad.1522907.
20. Wang X, Ye L, Hou W, Zhou Y, Wang YJ, Metzger DS, Ho WZ. 2009. Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113:671-674. http://dx.doi.org/10.1182/blood-2008-09-175000.
21. Chable-Bessia C, Meziane O, Latreille D, Triboulet R, Zamborlini A, Wagschal A, Jacquet JM, Reynes J, Levy Y, Saib A, Bennasser Y, Benkirane M. 2009. Suppression of HIV-1 replication by microRNA effectors. Retrovirology 6:26. http://dx.doi.org/10.1186/1742-4690-6-26.
22. Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, Hariharan M, Scaria V, Lalwani M, Pillai B, Mitra D, Brahmachari SK. 2008. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5:117. http://dx.doi.org/10.1186/1742-4690-5-117.
23. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM. 2009. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol. Cell 34:696-709. http://dx.doi.org/10.1016/j.molcel.2009.06.003.
24. Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H. 2007. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13:1241-1247. http://dx.doi.org/10.1038/nm1639.
25. Song L, Liu H, Gao S, Jiang W, Huang W. 2010. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J. Virol. 84:8849-8860. http://dx.doi.org/10.1128/JVI.00456-10.
26. Ma YJ, Yang J, Fan XL, Zhao HB, Hu W, Li ZP, Yu GC, Ding XR, Wang JZ, Bo XC, Zheng XF, Zhou Z, Wang SQ. 2012. Cellular microRNA let-7c inhibits M1 protein expression of the H1N1 influenza A virus in infected human lung epithelial cells. J. Cell. Mol. Med. 16:2539-2546. http://dx.doi.org/10.1111/j.1582-4934.2012.01572.x.
27. Zheng Z, Ke X, Wang M, He S, Li Q, Zheng C, Zhang Z, Liu Y, Wang H. 2013. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J. Virol. 87:5645-5656. http://dx.doi.org/10.1128/JVI.02655-12.
28. Otsuka M, Jing Q, Georgel P, New L, Chen J, Mols J, Kang YJ, Jiang Z, Du X, Cook R, Das SC, Pattnaik AK, Beutler B, Han J. 2007. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 27:123-134. http://dx.doi.org/10.1016/j.immuni.2007.05.014.
29. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O. 2005. A cellular microRNA mediates antiviral defense in human cells. Science 308:557-560. http://dx.doi.org/10.1126 /science.1108784.
30. O'Connor CM, Vanicek J, Murphy EA. 2014. Host miRNA regulation of human cytomegalovirus immediate early protein translation promotes viral latency. J. Virol. 88:5524-5532. http://dx.doi.org/10.1128 /JVI.00481-14.
31. Cullen BR. 2013. How do viruses avoid inhibition by endogenous cellular microRNAs? PLoS Pathog. 9:e1003694. http://dx.doi.org/10.1371/journal.ppat.1003694.
32. Davis M, Sagan SM, Pezacki JP, Evans DJ, Simmonds P. 2008. Bioinformatic and physical characterizations of genome-scale ordered RNA structure in mammalian RNA viruses. J. Virol. 82:11824-11836. http://dx.doi.org/10.1128/JVI.01078-08.
33. Ameres SL, Martinez J, Schroeder R. 2007. Molecular basis for target RNA recognition and cleavage by human RISC. Cell 130:101-112. http: //dx.doi.org/10.1016/j.cell.2007.04.037.
34. Gu S, Jin L, Zhang F, Sarnow P, Kay MA. 2009. Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs. Nat. Struct. Mol. Biol. 16:144-150. http://dx.doi.org/10.1038/nsmb.1552.
35. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577-1581. http://dx.doi.org/10.1126/science.1113329.
36. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. 2010. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 84:11670-11678. http: //dx.doi.org/10.1128/JVI.01248-10.
37. Ho BC, Yu SL, Chen JJ, Chang SY, Yan BS, Hong QS, Singh S, Kao CL, Chen HY, Su KY, Li KC, Cheng CL, Cheng HW, Lee JY, Lee CN, Yang PC. 2011. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe 9:58-69. http://dx.doi.org/10.1016/j.chom.2010.12.001.
38. Trobaugh DW, Gardner CL, Sun C, Haddow AD, Wang E, Chapnik E, Mildner A, Weaver SC, Ryman KD, Klimstra WB. 2014. RNA viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature 506:245-248. http://dx.doi.org/10.1038/nature12869.
39. Grundhoff A, Sullivan CS. 2011. Virus-encoded microRNAs. Virology 411:325-343. http://dx.doi.org/10.1016/j.virol.2011.01.002.
40. Cullen BR. 2011. Viruses and microRNAs: RISCy interactions with serious consequences. Genes Dev. 25:1881-1894. http://dx.doi.org/10.1101 /gad.17352611.
41. Bogerd HP, Whisnant AW, Kennedy EM, Flores O, Cullen BR. 2014. Derivation and characterization of Dicer-and microRNA-deficient human cells. RNA 20:923-937. http://dx.doi.org/10.1261/rna.044545.114.
42. Rossi SL, Zhao Q, O'Donnell VK, Mason PW. 2005. Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action. Virology 331:457-470. http://dx.doi.org/10.1016/j.virol.2004.10.046.
43. Umbach JL, Cullen BR. 2010. In-depth analysis of Kaposi's sarcomaassociated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery. J. Virol. 84:695-703. http: //dx.doi.org/10.1128/JVI.02013-09.
44. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10:R25. http://dx.doi.org/10.1186/gb-2009-10-3-r25.
45. Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, Nusbaum JD, Feederle R, Delecluse HJ, Luftig MA, Tuschl T, Ohler U, Cullen BR. 2012. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog. 8:e1002484. http://dx.doi.org/10.1371 /journal.ppat.1002484.
46. Bourne N, Scholle F, Silva MC, Rossi SL, Dewsbury N, Judy B, De Aguiar JB, Leon MA, Estes DM, Fayzulin R, Mason PW. 2007. Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J. Virol. 81:9100-9108. http://dx.doi.org/10.1128/JVI.00316-07.
47. Lustig S, Jackson AC, Hahn CS, Griffin DE, Strauss EG, Strauss JH. 1988. Molecular basis of Sindbis virus neurovirulence in mice. J. Virol. 62:2329-2336.
48. Kinney RM, Chang GJ, Tsuchiya KR, Sneider JM, Roehrig JT, Woodward TM, Trent DW. 1993. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J. Virol. 67:1269-1277.
49. Takeda M, Takeuchi K, Miyajima N, Kobune F, Ami Y, Nagata N, Suzaki Y, Nagai Y, Tashiro M. 2000. Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74:6643-6647. http://dx.doi.org/10.1128/JVI.74.14.6643-6647.2000.
50. Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y. 2001. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J. Virol. 75:4399-4401. http://dx.doi.org/10.1128/JVI.75.9.4399-4401.2001.
51. Kawakami E, Watanabe T, Fujii K, Goto H, Watanabe S, Noda T, Kawaoka Y. 2011. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J. Virol. Methods 173:1-6. http://dx.doi.org/10.1016/j.jviromet.2010.12.014.
52. Zurney J, Howard KE, Sherry B. 2007. Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses. J. Virol. 81:13668-13680. http://dx.doi.org/10.1128/JVI.01172-07.
53. Zurney J, Kobayashi T, Holm GH, Dermody TS, Sherry B. 2009. Reovirus mu2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9. J. Virol. 83:2178-2187. http://dx.doi.org/10.1128/JVI.01787-08.
54. Dutko JA, Schäfer A, Kenny AE, Cullen BR, Curcio MJ. 2005. Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr. Biol. 15:661-666. http://dx.doi.org/10.1016/j.cub.2005.02.051.
55. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC. 2002. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46:1896-1905. http://dx.doi.org/10.1128/AAC.46.6.1896-1905.2002.
56. Wiegand HL, Doehle BP, Bogerd HP, Cullen BR. 2004. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23:2451-2458. http://dx.doi.org/10.1038/sj.emboj.7600246.
57. Diamond TL, Roshal M, Jamburuthugoda VK, Reynolds HM, Merriam AR, Lee KY, Balakrishnan M, Bambara RA, Planelles V, Dewhurst S, Kim B. 2004. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J. Biol. Chem. 279:51545-51553. http://dx.doi.org/10.1074/jbc.M408573200.
58. van den Pol AN, Dalton KP, Rose JK. 2002. Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein. J. Virol. 76:1309-1327. http://dx.doi.org/10.1128/JVI.76.3.1309-1327.2002.
59. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
60. Núñez JI, Blanco E, Hernandez T, Gomez-Tejedor C, Martin MJ, Dopazo J, Sobrino F. 1998. A RT-PCR assay for the differential diagnosis of vesicular viral diseases of swine. J. Virol. Methods 72:227-235. http://dx.doi.org/10.1016/S0166-0934(98)00032-9.
61. Flores O, Nakayama S, Whisnant AW, Javanbakht H, Cullen BR, Bloom DC. 2013. Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture. J. Virol. 87:6589-6603. http://dx.doi.org/10.1128/JVI.00504-13.
62. Scott JC, Brackney DE, Campbell CL, Bondu-Hawkins V, Hjelle B, Ebel GD, Olson KE, Blair CD. 2010. Comparison of dengue virus type 2-specific small RNAs from RNA interference-competent and-incompetent mosquito cells. PLoS Negl. Trop. Dis. 4:e848. http://dx.doi.org/10.1371 /journal.pntd.0000848.
63. Hess AM, Prasad AN, Ptitsyn A, Ebel GD, Olson KE, Barbacioru C, Monighetti C, Campbell CL. 2011. Small RNA profiling of dengue virus-mosquito interactions implicates the PIWI RNA pathway in antiviral defense. BMC Microbiol. 11:45. http://dx.doi.org/10.1186/1471-2180-11-45.
64. Hussain M, Asgari S. 2014. MicroRNA-like viral small RNA from dengue virus 2 autoregulates its replication in mosquito cells. Proc. Natl. Acad. Sci. U. S. A. 111:2746-2751. http://dx.doi.org/10.1073/pnas.1320123111.
65. Kakumani PK, Ponia SS, Rajgokul KS, Sood V, Chinnappan M, Banerjea AC, Medigeshi G, Malhotra P, Mukherjee SK, Bhatnagar RK. 2013. Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor. J. Virol. 87:8870-8883. http://dx.doi.org/10.1128/JVI.02774-12.
66. Hussain M, Torres S, Schnettler E, Funk A, Grundhoff A, Pijlman GP, Khromykh AA, Asgari S. 2012. West Nile virus encodes a microRNA-like small RNA in the 3' untranslated region which up-regulates GATA4 mRNA and facilitates virus replication in mosquito cells. Nucleic Acids Res. 40:2210-2223. http://dx.doi.org/10.1093/nar/gkr848.
67. Brackney DE, Beane JE, Ebel GD. 2009. RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification. PLoS Pathog. 5:e1000502. http://dx.doi.org/10.1371/journal.ppat.1000502.
68. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297. http://dx.doi.org/10.1016/S0092-8674(04)00045-5.
69. Ciaudo C, Jay F, Okamoto I, Chen CJ, Sarazin A, Servant N, Barillot E, Heard E, Voinnet O. 2013. RNAi-dependent and independent control of LINE1 accumulation and mobility in mouse embryonic stem cells. PLoS Genet. 9:e1003791. http://dx.doi.org/10.1371/journal.pgen.1003791.
70. Babiarz JE, Ruby JG, Wang Y, Bartel DP, Blelloch R. 2008. Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessorindependent, Dicer-dependent small RNAs. Genes Dev. 22:2773-2785. http://dx.doi.org/10.1101/gad.1705308.
71. Yi R, O'Carroll D, Pasolli HA, Zhang Z, Dietrich FS, Tarakhovsky A, Fuchs E. 2006. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat. Genet. 38:356-362. http://dx.doi.org/10.1038/ng1744.
72. Shapiro JS, Varble A, Pham AM, tenOever BR. 2010. Noncanonical cytoplasmic processing of viral microRNAs. RNA 16:2068-2074. http: //dx.doi.org/10.1261/rna.2303610.
73. Galiana-Arnoux D, Dostert C, Schneemann A, Hoffmann JA, Imler JL. 2006. Essential function in vivo for Dicer-2 in host defense against RNA viruses in drosophila. Nat. Immunol. 7:590-597. http://dx.doi.org/10.1038/ni1335.
74. Perez JT, Pham AM, Lorini MH, Chua MA, Steel J, tenOever BR. 2009. MicroRNA-mediated species-specific attenuation of influenza A virus. Nat. Biotechnol. 27:572-576. http://dx.doi.org/10.1038/nbt.1542.
75. Langlois RA, Albrecht RA, Kimble B, Sutton T, Shapiro JS, Finch C, Angel M, Chua MA, Gonzalez-Reiche AS, Xu K, Perez D, Garcia-Sastre A, tenOever BR. 2013. MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies. Nat. Biotechnol. 31:844-847. http: //dx.doi.org/10.1038/nbt.2666.
76. Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R. 2008. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 4:239-248. http://dx.doi.org/10.1016/j.chom.2008.08.003.
77. Ylösmäki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, Saksela K. 2008. Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific microRNA. J. Virol. 82:11009-11015. http://dx.doi.org/10.1128/JVI.01608-08.
78. Kelly EJ, Hadac EM, Greiner S, Russell SJ. 2008. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 14:1278-1283. http://dx.doi.org/10.1038/nm.1776.
79. Seo GJ, Kincaid RP, Phanaksri T, Burke JM, Pare JM, Cox JE, Hsiang TY, Krug RM, Sullivan CS. 2013. Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host Microbe 14:435-445. http://dx.doi.org/10.1016/j.chom.2013.09.002.
80. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW, Jr, Swanstrom R, Burch CL, Weeks KM. 2009. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460:711-716. http://dx.doi.org/10.1038/nature08237.
81. Tan X, Lu ZJ, Gao G, Xu Q, Hu L, Fellmann C, Li MZ, Qu H, Lowe SW, Hannon GJ, Elledge SJ. 2012. Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy. Proc. Natl. Acad. Sci. U. S. A. 109:869-874. http://dx.doi.org/10.1073/pnas.1119873109.
82. Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA. 2012. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 31:2207-2221. http://dx.doi.org/10.1038/emboj.2012.63.
83. Pan D, Flores O, Umbach JL, Pesola JM, Bentley P, Rosato PC, Leib DA, Cullen BR, Coen DM. 2014. A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency. Cell Host Microbe 15:446-456. http://dx.doi.org/10.1016/j.chom.2014.03.004.